Last edition
News about Market
Samsung Bioepis and Epis NexLab Partner G2GBIO to Develop Long-Acting Semaglutide
Samsung Bioepis and Epis NexLab have signed a research collaboration and licensing agreement with G2GBIO to develop novel assets, including long-acting semaglutide, using G2GBIO’s proprietary microsphere drug delivery technology.
Market | 16/03/2026 | By News Bureau | 124
Roche Pharma India partners with the Government of Punjab to launch NeuroSakhi, a patient support and awareness programme aimed at improving diagnosis, care pathways and treatment access for women with multiple sclerosis.
Market | 13/03/2026 | By News Bureau | 143
Earendil Labs and WuXi Biologics Partner on Bispecific Antibodies and ADCs
Under the agreement, WuXi Biologics will provide end-to-end development and manufacturing services to Earendil Labs, supporting faster regulatory timelines, reliable CMC execution, and scalable global clinical development.
Market | 13/03/2026 | By News Bureau | 136
Veristat Expands Global Regulatory And Clinical Trial Support For Pharma Companies
Veristat, a global clinical research organization (CRO) and regulatory consultancy, has expanded its regulatory and clinical trial support services to help international pharmaceutical and medical device companies navigate approvals in key global markets, including the United Kingdom, Switzerland, Australia, Canada and the United States.
Market | 12/03/2026 | By Darshana | 115
MiNK Therapeutics collaborates with C-Further consortium to develop PRAME-targeted TCR-engineered iNKT cell therapy for paediatric cancers, aiming to deliver innovative immunotherapy options for children with limited treatment alternatives.
Market | 12/03/2026 | By News Bureau
Immunic Secures European Patent for Vidofludimus Calcium, Strengthening Long-Term Market Exclusivity
Immunic receives European patent protection for Vidofludimus Calcium dosing regimens, reinforcing intellectual property coverage and potentially extending exclusivity for the multiple sclerosis therapy in Europe until 2043.
Market | 12/03/2026 | By News Bureau | 106
Serum Institute and Bavarian Nordic Expand Partnership for Chikungunya Vaccine Manufacturing
Bavarian Nordic and Serum Institute of India have expanded their strategic partnership through a chikungunya vaccine manufacturing agreement, enabling full technology transfer and supporting future supply to low- and middle-income countries while opening opportunities for further co-development.
Market | 11/03/2026 | By News Bureau | 192
API Exports Reach INR 41,500 Crore, Overtake Imports In FY25
India’s exports of active pharmaceutical ingredients (APIs) exceeded imports in the financial year 2024–25, reflecting the country’s strengthening capabilities in bulk drug manufacturing.
Market | 11/03/2026 | By Darshana | 328
Medtronic Signs USD 550 Million Deal To Buy Scientia Vascular
Medtronic plc has entered into a definitive agreement to acquire Scientia Vascular for USD 550 million, as the medical technology giant looks to strengthen its neurovascular portfolio and expand capabilities in stroke treatment.
Market | 11/03/2026 | By Darshana | 128
Agilent to Acquire Biocare Medical
Agilent Technologies has agreed to acquire Biocare Medical, expanding its pathology portfolio with complementary antibodies, reagents and instruments. The acquisition is expected to strengthen Agilent’s revenue growth, margin profile and non-instrument revenue mix from the first year.
Market | 11/03/2026 | By News Bureau | 106
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy